LOGIN
TEAM
CONTACT US
COLLECTIONS
Bladder
Breast
Leukemia
Liver
Sarcoma
HOME
You need to enable JavaScript to run this app page.
Breast
BCM-0132
Model Details
Patient
PDX Model
Histology
Metastasis
Patient Treatment
Patient Information for Model: BCM-0132
Patient Information
Clinical Timeline
Color Keys:
Positive
Negative
N/A
Clinical Information at Collection
Clinical Biomarkers/Mutations at Collection
Pathology Information at Collection
Model Information for Model: BCM-0132
Model Details - Initial Implantation of Patient Tissue
Biomarkers & Mutations
Model Details - Acceptable Conditions for Passaging
Mutations (Cancer Gene Census List)
Show/Hide Columns
The number of models in this collection with mutations in the listed gene;
may include models that are not publicly available for distribution.
The number of models in this collection with mutations at the listed site;
may include models that are not publicly available for distribution.
Total mutations showing: 66
F
P
1
2
3
4
5
N
E
Rows Per Page
10
15
25
50
Download
Gene
Filter by Gene
Chr
Filter by Chr
Start
End
Ref
Alt
cDNA Change
Codon Change
Protein Change
TVAF
Gene Mutation Freq.
Site Mutation Freq.
Most Severe Effect
All Effects
Mutation Impact
Transcript ID
ClinVar Clinical Significance
COSMIC ID
gnomAD Non-Cancer AF
dbSNP ID
Gene Mutation Freq.
Site Mutation Freq.
Transcript ID
ClinVar Clinical Significance
COSMIC ID
dbSNP ID
AFF4
chr5
132897083
132897103
GTGTAGCTATTCCCAGTGCCC
G
c.1527_1546del
caGGGCACTGGGAATAGCTACAct/cact
p.Q509Hfs*2
0.523
7
1
Frameshift Mutation
Frameshift Mutation
HIGH
ENST00000265343.10
7
1
ENST00000265343.10
AR
chrX
67546514
67546517
TGGC
T
c.1418_1420del
GGC/-
p.G473del
0.858
48
3
In-frame Deletion
In-frame Deletion
MODERATE
ENST00000374690.9
COSV65958513
48
3
ENST00000374690.9
COSV65958513
ARID1A
chr1
26696761
26696761
C
T
c.358C>T
Ccg/Tcg
p.P120S
0.952
19
2
Missense Variant
Missense Variant
MODERATE
ENST00000324856.13
Conflicting_interpretations_of_pathogenicity
COSV61373973
0.000271628000
rs571264557
19
2
ENST00000324856.13
Conflicting_interpretations_of_pathogenicity
COSV61373973
rs571264557
ARID1B
chr6
157206530
157206534
CTGTT
C
c.5763_5766del
cTGTTt/ct
p.F1921Lfs*52
0.937
37
1
Frameshift Mutation
Frameshift Mutation
HIGH
ENST00000636930.2
COSV99269679
rs1554237269
37
1
ENST00000636930.2
COSV99269679
rs1554237269
BIRC6
chr2
32529771
32529771
C
T
c.12041C>T
aCa/aTa
p.T4014I
1.0
15
1
Missense Variant
Missense Variant
MODERATE
ENST00000421745.6
0.000038112000
rs141336419
15
1
ENST00000421745.6
rs141336419
BRCA2
chr13
32340575
32340575
C
A
c.6220C>A
Cac/Aac
p.H2074N
0.985
21
2
Missense Variant
Missense Variant
MODERATE
ENST00000380152.7
Benign
0.000727523000
rs34309943
21
2
ENST00000380152.7
Benign
rs34309943
BUB1B
chr15
40196656
40196656
G
C
c.1170G>C
gaG/gaC
p.E390D
0.985
5
3
Missense Variant
Missense Variant
MODERATE
ENST00000287598.11
Benign
COSV55010791
0.008655650000
rs1017842
5
3
ENST00000287598.11
Benign
COSV55010791
rs1017842
CIITA
chr16
10909070
10909070
A
G
c.2702A>G
cAg/cGg
p.Q901R
0.386
85
84
Missense Variant
Missense Variant
MODERATE
ENST00000618327.4
Benign
0.983235000000
rs7197779
85
84
ENST00000618327.4
Benign
rs7197779
CLTCL1
chr22
19219970
19219970
C
T
c.2834G>A
cGc/cAc
p.R945H
0.444
19
3
Missense Variant
Missense Variant
MODERATE
ENST00000427926.6
Benign
COSV99067208
0.003138280000
rs36077768
19
3
ENST00000427926.6
Benign
COSV99067208
rs36077768
COL1A1
chr17
50188134
50188134
C
T
c.3223G>A
Gcc/Acc
p.A1075T
0.996
11
3
Missense Variant
Missense Variant
MODERATE
ENST00000225964.10
Benign
rs1800215
11
3
ENST00000225964.10
Benign
rs1800215
ELK4
chr1
205620109
205620109
C
T
c.937G>A
Gta/Ata
p.V313I
0.483
3
1
Missense Variant
Missense Variant
MODERATE
ENST00000357992.9
0.000244833000
rs34515238
3
1
ENST00000357992.9
rs34515238
EPHA3
chr3
89210224
89210224
C
G
c.518C>G
cCt/cGt
p.P173R
0.528
5
1
Missense Variant
Missense Variant
MODERATE
ENST00000336596.7
5
1
ENST00000336596.7
ERCC5
chr13
102854340
102854340
G
A
c.433G>A
Gtt/Att
p.V145I
0.962
14
1
Missense Variant
Missense Variant
MODERATE
ENST00000652225.2
Benign/Likely_benign
COSV104673176
0.001582750000
rs4987063
14
1
ENST00000652225.2
Benign/Likely_benign
COSV104673176
rs4987063
ESR1
chr6
151808321
151808321
A
G
c.409A>G
Agc/Ggc
p.S137G
0.976
10
3
Missense Variant
Missense Variant
MODERATE
ENST00000440973.5
Benign
0.000500829000
rs185717042
10
3
ENST00000440973.5
Benign
rs185717042
ETV5
chr3
186080022
186080022
G
C
c.445C>G
Cta/Gta
p.L149V
0.562
4
1
Missense Variant
Missense Variant
MODERATE
ENST00000306376.10
Benign
0.002721030000
rs78506201
4
1
ENST00000306376.10
Benign
rs78506201
Total mutations showing: 66
F
P
1
2
3
4
5
N
E
Rows Per Page
10
15
25
50
Download
CNV
There are no omics data for this model.
Histology Information for Model: BCM-0132
Patient
PDX
ER
HER2
PR
Metastasis Information for Model: BCM-0132
Patient
PDX
Abdomen
Abdominal cavity
Adrenal Gland
Anterosuperior mediastinum
Ascites
Axillary Lymph Node
Bone
Brain
CTC
Chest
Chest wall
Contralateral Breast
Fallopian tubes
Head
Hilar Node
Hip
Kidney
Leg bone
Leptomeninges
Liver
Lung
Lymph Node
Mediastinum
Metastasis Pleura
Neck
None
Other
Ovary
Pancreas
Paratracheal adenopathy
Pericardium
Peritoneal cavity
Peritoneum
Pleura
Pleural cavity
Pleural effusion
Posterior cervical nodes
Pulmonary
Retrocrural Lymph Node
SVC node
Sacral Spine
Skin
Spine
Spleen
Thymus
Patient Treatment Information for Model: BCM-0132
Event Id
Treatment
Treatment Setting
Age at Start
Age at End
Duration
Clinical Response
Pathologic Response
Reason Stopped
15
Doxorubicin, Cyclophosphamide
Neoadjuvant
58.92
59.03
40 days
Partial Response
Not Applicable
Treatment Completed
20
Carboplatin,Paclitaxel
Neoadjuvant
59.09
59.34
91 days
Complete Response
Partial Response
Treatment Completed
30
Docetaxel
Adjuvant
59.46
59.63
62 days
Not Reported
Not Applicable
Treatment Completed
35
Radiation Therapy (RT)
Adjuvant
59.76
59.84
29 days
Not Reported
Not Applicable
Treatment Completed
40
Capecitabine
Adjuvant
59.95
60.39
161 days
Stable Disease
Not Applicable
Treatment Completed
Timeout
Your session is about to expire. Click 'Stay Connected' to continue the session.
Stay Connected